- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Bronchospasm
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 853KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 47KB)
Terbutaline – July 2020
Terbutaline: Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 120 doses; Bricanyl® Turbuhaler
Last updated
30 October 2020